Item Type | Name |
Academic Article
|
Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer.
|
Academic Article
|
A role for curative surgery in the treatment of selected patients with metastatic breast cancer.
|
Academic Article
|
Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women
|
Academic Article
|
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged
|
Academic Article
|
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer.
|
Academic Article
|
Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
|
Academic Article
|
Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis.
|
Academic Article
|
Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol.
|
Academic Article
|
Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.
|
Academic Article
|
Immediate breast reconstruction can impact postmastectomy irradiation.
|
Academic Article
|
Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy.
|
Academic Article
|
Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years.
|
Academic Article
|
The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy.
|
Academic Article
|
Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes.
|
Academic Article
|
How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?
|
Academic Article
|
Prognostic value of initial clinical disease stage after achieving pathological complete response.
|
Academic Article
|
Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.
|
Academic Article
|
Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density.
|
Academic Article
|
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.
|
Academic Article
|
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer.
|
Academic Article
|
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.
|
Academic Article
|
Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid.
|
Academic Article
|
Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer.
|
Academic Article
|
Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma.
|
Academic Article
|
Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer.
|
Academic Article
|
Comparative analysis of sentinel lymph node operation in male and female breast cancer patients.
|
Academic Article
|
Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.
|
Concept
|
Breast Neoplasms, Male
|
Concept
|
Breast
|
Concept
|
Breast Diseases
|
Concept
|
Breast Neoplasms
|
Concept
|
Carcinoma, Ductal, Breast
|
Academic Article
|
Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.
|
Academic Article
|
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial.
|
Academic Article
|
Expression of c-kit proto-oncogene product in breast tissue.
|
Academic Article
|
Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer.
|
Academic Article
|
Functional consequence of the MET-T1010I polymorphism in breast cancer.
|
Academic Article
|
HER2/neu in the management of invasive breast cancer.
|
Academic Article
|
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
|
Academic Article
|
Histologic localization of sentinel lymph node metastases in breast cancer.
|
Academic Article
|
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
|
Academic Article
|
Determinants of rapamycin sensitivity in breast cancer cells.
|
Academic Article
|
Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
|
Academic Article
|
Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.
|
Academic Article
|
Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells.
|
Academic Article
|
Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
|
Academic Article
|
Paget's disease of the breast: there is a role for breast-conserving therapy.
|
Academic Article
|
Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
|
Academic Article
|
Potential role of mammalian target of rapamycin inhibitors in breast cancer therapy.
|
Academic Article
|
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
|
Academic Article
|
Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center.
|
Academic Article
|
Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
|
Academic Article
|
Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?
|
Academic Article
|
Trends for inflammatory breast cancer: is survival improving?
|
Academic Article
|
Commonly cited website quality criteria are not effective at identifying inaccurate online information about breast cancer.
|
Academic Article
|
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer.
|
Academic Article
|
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy.
|
Academic Article
|
Translation initiation factor 4E (eIF4E): prognostic marker and potential therapeutic target.
|
Academic Article
|
Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications.
|
Academic Article
|
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.
|
Academic Article
|
Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
|
Academic Article
|
Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers.
|
Academic Article
|
BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment.
|
Academic Article
|
Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer.
|
Academic Article
|
Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.
|
Academic Article
|
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.
|
Academic Article
|
Biology, treatment, and outcome in very young and older women with DCIS.
|
Academic Article
|
Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy.
|
Academic Article
|
Genotype in BRCA-associated breast cancers.
|
Academic Article
|
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer.
|
Academic Article
|
Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes.
|
Academic Article
|
Promising rationally derived combination therapy with PI3K and CDK4/6 inhibitors.
|
Academic Article
|
Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer.
|
Academic Article
|
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.
|
Academic Article
|
Expression profile of tyrosine kinases in breast cancer.
|
Academic Article
|
Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites.
|
Academic Article
|
Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy.
|
Academic Article
|
Radiofrequency ablation of early-stage invasive breast tumors: an overview.
|
Academic Article
|
Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
|
Academic Article
|
Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.
|
Academic Article
|
Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery.
|
Academic Article
|
Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
|
Academic Article
|
Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.
|
Academic Article
|
Expression of sigma 1 receptor in human breast cancer.
|
Academic Article
|
Breast conservation after neoadjuvant chemotherapy.
|
Academic Article
|
Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
|
Academic Article
|
Improving local control with breast-conserving therapy: a 27-year single-institution experience.
|
Academic Article
|
Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
|
Academic Article
|
Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways.
|
Academic Article
|
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
|
Academic Article
|
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
|
Academic Article
|
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
|
Academic Article
|
Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer.
|
Academic Article
|
Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
|
Academic Article
|
Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
|
Academic Article
|
Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival.
|
Academic Article
|
Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.
|
Academic Article
|
Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.
|
Academic Article
|
Currency of online breast cancer information.
|
Academic Article
|
Development of new cancers in patients with DCIS: the M.D. Anderson experience.
|
Academic Article
|
Prognostic significance of HER-2 status in women with inflammatory breast cancer.
|
Academic Article
|
Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.
|
Academic Article
|
eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling.
|
Academic Article
|
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.
|
Academic Article
|
Building a predictive breast cancer risk model.
|
Academic Article
|
Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients.
|
Academic Article
|
Regulation and localization of ribosomal protein S6 kinase 1 isoforms.
|
Academic Article
|
High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.
|
Academic Article
|
The impact of pregnancy on breast cancer outcomes in women
|
Academic Article
|
Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
|
Academic Article
|
Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer.
|
Academic Article
|
Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival.
|
Academic Article
|
Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients.
|
Academic Article
|
Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment.
|
Academic Article
|
Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.
|
Academic Article
|
ASBrS and ASO: a new partnership begins.
|
Academic Article
|
Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.
|
Academic Article
|
Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer.
|
Academic Article
|
Sentinel lymph node dissection is technically feasible in older breast cancer patients.
|
Academic Article
|
A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes.
|
Academic Article
|
The effect of leucine restriction on Akt/mTOR signaling in breast cancer cell lines in vitro and in vivo.
|
Academic Article
|
Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial.
|
Academic Article
|
Quantitative proteomic analysis in breast cancer.
|
Academic Article
|
PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.
|
Academic Article
|
Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients.
|
Academic Article
|
Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer.
|
Academic Article
|
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.
|
Academic Article
|
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.
|
Academic Article
|
Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience.
|
Academic Article
|
Earlier age of onset of BRCA mutation-related cancers in subsequent generations.
|
Academic Article
|
cMET and phospho-cMET protein levels in breast cancers and survival outcomes.
|
Academic Article
|
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.
|
Academic Article
|
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.
|
Academic Article
|
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer.
|
Academic Article
|
Multifocality and multicentricity in breast cancer and survival outcomes.
|
Academic Article
|
Biomarkers of response to Akt inhibitor MK-2206 in breast cancer.
|
Academic Article
|
Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population.
|
Academic Article
|
High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients.
|
Academic Article
|
Locoregional interaction of ixabepilone (ixempra) after breast cancer radiation.
|
Academic Article
|
Emergence of constitutively active estrogen receptor-a mutations in pretreated advanced estrogen receptor-positive breast cancer.
|
Academic Article
|
Adenovirus 5 early region 1A does not induce expression of the ewing sarcoma fusion product EWS-FLI1 in breast and ovarian cancer cell lines.
|
Academic Article
|
Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience.
|
Academic Article
|
Long-term complications associated with breast-conservation surgery and radiotherapy.
|
Academic Article
|
Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge.
|
Academic Article
|
Chest wall recurrence after mastectomy does not always portend a dismal outcome.
|
Academic Article
|
Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.
|
Academic Article
|
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.
|
Academic Article
|
Serum proteomics for BRCA1-associated breast cancer.
|
Academic Article
|
Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
|
Academic Article
|
Determinants of mastectomy in breast conservation therapy candidates.
|
Academic Article
|
Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.
|
Academic Article
|
Accuracy and self correction of information received from an internet breast cancer list: content analysis.
|
Academic Article
|
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.
|
Academic Article
|
Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.
|
Academic Article
|
Selective use of sentinel lymph node surgery during prophylactic mastectomy.
|
Academic Article
|
Advances in targeting human epidermal growth factor receptor-2 signaling for cancer therapy.
|
Academic Article
|
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
|
Academic Article
|
Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis.
|
Academic Article
|
Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
|
Academic Article
|
Heterogenic loss of BRCA in breast cancer: the "two-hit" hypothesis takes a hit.
|
Academic Article
|
Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.
|
Academic Article
|
Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy.
|
Academic Article
|
Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases.
|
Academic Article
|
Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach.
|
Academic Article
|
RNA-binding specificity of Y-box protein 1.
|
Academic Article
|
Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.
|
Academic Article
|
A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.
|
Academic Article
|
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.
|
Academic Article
|
Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation.
|
Academic Article
|
Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer.
|
Academic Article
|
Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery.
|
Academic Article
|
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
|
Academic Article
|
Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients.
|
Academic Article
|
False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden.
|
Academic Article
|
The rapamycin-regulated gene expression signature determines prognosis for breast cancer.
|
Academic Article
|
Metformin: a therapeutic opportunity in breast cancer.
|
Academic Article
|
Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.
|
Academic Article
|
A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.
|
Academic Article
|
Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.
|
Academic Article
|
Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.
|
Academic Article
|
Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis.
|
Academic Article
|
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
|
Academic Article
|
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
|
Academic Article
|
Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance.
|
Academic Article
|
Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer.
|
Academic Article
|
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.
|
Academic Article
|
Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype.
|
Academic Article
|
Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer.
|
Academic Article
|
Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers.
|
Academic Article
|
Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
|
Academic Article
|
Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancer.
|
Academic Article
|
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
|
Academic Article
|
Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy.
|
Academic Article
|
American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.
|
Academic Article
|
Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment.
|
Academic Article
|
Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.
|
Academic Article
|
Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy.
|
Academic Article
|
Two birds with one stone: octreotide treatment for acromegaly and breast cancer.
|
Academic Article
|
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.
|
Academic Article
|
Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?
|
Academic Article
|
Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients.
|
Academic Article
|
Reply to letter: "Waiting time for breast cancer treatment".
|
Academic Article
|
Breast-conservation therapy in early-stage breast cancer patients with a positive family history.
|
Academic Article
|
Molecular profiles of invasive mucinous and ductal carcinomas of the breast: a molecular case study.
|
Academic Article
|
Breast conservation in breast cancer: surgical and adjuvant considerations.
|
Academic Article
|
Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
|
Academic Article
|
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
|
Academic Article
|
Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
|
Academic Article
|
Does blue dye contribute to success of sentinel node mapping for breast cancer?
|
Academic Article
|
Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
|
Academic Article
|
Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy.
|
Academic Article
|
Breast cancer multifocality and multicentricity and locoregional recurrence.
|
Academic Article
|
Attitudes regarding privacy of genomic information in personalized cancer therapy.
|
Academic Article
|
Treatment and outcome of patients with intracystic papillary carcinoma of the breast.
|
Academic Article
|
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy.
|
Academic Article
|
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
|
Academic Article
|
Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
|
Academic Article
|
Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes.
|
Academic Article
|
Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue.
|
Academic Article
|
Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy.
|
Academic Article
|
Triple-negative breast cancer is not a contraindication for breast conservation.
|
Academic Article
|
Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer.
|
Academic Article
|
Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.
|
Academic Article
|
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.
|
Academic Article
|
Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy.
|
Academic Article
|
PD-L1 expression in triple-negative breast cancer.
|
Academic Article
|
Clonal evolution in breast cancer revealed by single nucleus genome sequencing.
|
Academic Article
|
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer.
|
Academic Article
|
Which threshold for ER positivity? a retrospective study based on 9639 patients.
|
Academic Article
|
Concordance of genomic alterations between primary and recurrent breast cancer.
|
Academic Article
|
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer?.
|
Academic Article
|
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms.
|
Academic Article
|
Influence of biospecimen variables on proteomic biomarkers in breast cancer.
|
Academic Article
|
Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer.
|
Academic Article
|
Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017.
|
Academic Article
|
Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit.
|
Academic Article
|
Attitudes toward molecular testing for personalized cancer therapy.
|
Academic Article
|
Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents.
|
Academic Article
|
Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.
|
Academic Article
|
Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.
|
Academic Article
|
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer.
|
Academic Article
|
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.
|
Academic Article
|
Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer.
|
Academic Article
|
Epithelial to mesenchymal transition is associated with rapamycin resistance.
|
Academic Article
|
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
|
Academic Article
|
A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer.
|
Academic Article
|
Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.
|
Academic Article
|
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.
|
Academic Article
|
Targeting translation initiation in breast cancer.
|
Academic Article
|
mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer.
|
Academic Article
|
Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
|
Academic Article
|
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
|
Academic Article
|
Currency of online breast cancer information
|
Academic Article
|
Breast conservation after neoadjuvant chemotherapy
|
Academic Article
|
Locally advanced breast cancer
|
Academic Article
|
Predictors of systemic recurrence and impact of local failure among early stage breast cancer patients treated with breast conserving therapy
|
Academic Article
|
High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer
|
Academic Article
|
Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy
|
Academic Article
|
Breast cancer metastatic to abdomen and pelvis
|
Academic Article
|
A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer
|
Academic Article
|
Erratum
|
Academic Article
|
High Risk of Contralateral Breast Carcinoma in Women With Hereditary/Familial Non-BRCA1/BRCA2 Breast Carcinoma
|
Academic Article
|
Next-generation sequencing
|
Academic Article
|
Ability to generate patient-derived Breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes
|
Academic Article
|
Breast conservation after neoadjuvant chemotherapy
|
Academic Article
|
Ribociclib plus letrozole in early breast cancer
|
Academic Article
|
Axillary Reverse Mapping (ARM)
|
Academic Article
|
Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast
|
Academic Article
|
mTOR inhibitors suppress homologous recombination repair and synergize with PARP inhibitors via regulating SUV39H1 in BRCA-proficient triple-negative breast cancer
|
Academic Article
|
Chest wall recurrence after mastectomy does not always portend a dismal outcome
|
Academic Article
|
Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors
|
Academic Article
|
Erratum
|
Academic Article
|
Clinical outcomes based on multigene profiling in metastatic breast cancer patients
|
Academic Article
|
Quality and accuracy of breast cancer information on the World Wide Web
|
Academic Article
|
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
|
Academic Article
|
Risk of ipsilateral and contralateral cancer in BRCA mutation carriers with breast cancer
|
Academic Article
|
Growth inhibition of breast cancer cells by celecoxib
|
Academic Article
|
Punctuated copy number evolution and clonal stasis in triple-negative breast cancer
|
Academic Article
|
Phase II Randomized Study of Ixabepilone Versus Observation in Patients with Significant Residual Disease after Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer
|
Academic Article
|
Intraoperative Margin Analysis in Breast-Conserving Surgery
|
Academic Article
|
Genotype-phenotype correlations by ethnicity and mutation location in brca mutation carriers
|
Academic Article
|
Paget's disease of the breast
|
Academic Article
|
High intratumoral stromal content defines reactive breast cancer as a low-risk breast cancer subtype
|
Academic Article
|
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.
|
Academic Article
|
High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer: a pilot study.
|
Academic Article
|
Risk of Ipsilateral and Contralateral Cancer in BRCA Mutation Carriers with Breast Cancer.
|
Academic Article
|
Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.
|
Academic Article
|
Patient knowledge and information-seeking about personalized cancer therapy.
|
Academic Article
|
Punctuated copy number evolution and clonal stasis in triple-negative breast cancer.
|
Academic Article
|
Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors.
|
Academic Article
|
High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype.
|
Academic Article
|
Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study.
|
Academic Article
|
Clinical outcomes based on multigene profiling in metastatic breast cancer patients.
|
Academic Article
|
Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.
|
Academic Article
|
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab.
|
Academic Article
|
Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapy.
|
Academic Article
|
Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy.
|
Academic Article
|
Identification of frequent somatic mutations in inflammatory breast cancer.
|
Academic Article
|
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.
|
Academic Article
|
Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer.
|
Academic Article
|
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.
|
Academic Article
|
Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer.
|
Academic Article
|
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.
|
Academic Article
|
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.
|
Academic Article
|
Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers.
|
Academic Article
|
Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.
|
Academic Article
|
Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer.
|
Academic Article
|
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.
|
Academic Article
|
Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis.
|
Academic Article
|
Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.
|
Academic Article
|
Molecular determinants of post-mastectomy breast cancer recurrence.
|
Academic Article
|
OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients.
|
Academic Article
|
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.
|
Academic Article
|
MK-2206 window of opportunity study in breast cancer.
|
Academic Article
|
FGFR1? is a driver isoform of FGFR1 alternative splicing in breast cancer cells.
|
Academic Article
|
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.
|
Concept
|
Inflammatory Breast Neoplasms
|
Concept
|
Triple Negative Breast Neoplasms
|
Academic Article
|
Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.
|
Academic Article
|
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation.
|
Academic Article
|
HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological features.
|
Academic Article
|
TAK228 enhances antitumor activity of eribulin in triple negative breast cancer.
|
Academic Article
|
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.
|
Academic Article
|
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib.
|
Academic Article
|
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.
|
Academic Article
|
Correction: FGFR1? is a driver isoform of FGFR1 alternative splicing in breast cancer cells.
|
Academic Article
|
Characteristics and Outcome of AKT1E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry.
|
Academic Article
|
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study.
|
Academic Article
|
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.
|
Academic Article
|
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations.
|
Academic Article
|
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
|
Academic Article
|
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid Tumors.
|
Academic Article
|
Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer.
|
Academic Article
|
First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models.
|
Academic Article
|
Breast tumours maintain a reservoir of subclonal diversity during expansion.
|
Academic Article
|
Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer.
|
Academic Article
|
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer.
|
Academic Article
|
Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial.
|
Academic Article
|
Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations.
|
Academic Article
|
Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy.
|
Academic Article
|
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers.
|
Academic Article
|
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer.
|
Academic Article
|
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
|
Academic Article
|
Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIE.
|
Academic Article
|
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.
|
Academic Article
|
Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer.
|
Academic Article
|
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers.
|
Academic Article
|
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.
|
Academic Article
|
Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing.
|
Academic Article
|
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.
|
Academic Article
|
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study.
|
Academic Article
|
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers.
|
Academic Article
|
HER2-low expression in patients with advanced or metastatic solid tumors.
|
Academic Article
|
To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?
|
Academic Article
|
Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan.
|
Academic Article
|
Multidisciplinary Care of a Large Brain Metastasis in a Patient with Hormone-Receptor-Positive Breast Cancer with Ataxia-Telangiectasia Mutation.
|
Academic Article
|
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.
|
Academic Article
|
Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer.
|
Academic Article
|
Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.
|
Academic Article
|
Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer.
|
Academic Article
|
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
|
Academic Article
|
Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer.
|
Academic Article
|
Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan.
|